Put Options

15 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$145.48 - $167.38 $18 Million - $20.7 Million
123,500 Added 231.27%
176,900 $28.7 Million
Q2 2024

Aug 14, 2024

BUY
$144.38 - $157.78 $6.15 Million - $6.72 Million
42,600 Added 394.44%
53,400 $7.8 Million
Q1 2024

May 13, 2024

SELL
$155.22 - $162.74 $5.31 Million - $5.57 Million
-34,200 Reduced 76.0%
10,800 $1.71 Million
Q4 2023

Feb 14, 2024

BUY
$145.6 - $158.88 $1.49 Million - $1.62 Million
10,200 Added 29.31%
45,000 $7.05 Million
Q3 2023

Nov 14, 2023

BUY
$155.75 - $174.48 $5.42 Million - $6.07 Million
34,800 New
34,800 $5.42 Million
Q1 2023

May 15, 2023

SELL
$151.05 - $180.26 $33 Million - $39.4 Million
-218,400 Reduced 61.75%
135,300 $21 Million
Q4 2022

Feb 14, 2023

BUY
$160.2 - $179.79 $19.3 Million - $21.6 Million
120,300 Added 51.54%
353,700 $62.5 Million
Q3 2022

Nov 14, 2022

BUY
$161.33 - $179.52 $19.8 Million - $22 Million
122,500 Added 110.46%
233,400 $38.1 Million
Q2 2022

Aug 15, 2022

BUY
$168.19 - $186.01 $5.42 Million - $5.99 Million
32,200 Added 40.91%
110,900 $19.7 Million
Q1 2022

May 16, 2022

BUY
$158.14 - $179.59 $10.9 Million - $12.4 Million
69,000 Added 711.34%
78,700 $13.9 Million
Q2 2021

Aug 16, 2021

SELL
$159.48 - $171.07 $4.83 Million - $5.18 Million
-30,300 Reduced 75.75%
9,700 $1.6 Million
Q1 2020

May 15, 2020

SELL
$111.14 - $153.99 $17.8 Million - $24.6 Million
-160,000 Reduced 80.0%
40,000 $5.25 Million
Q1 2019

May 15, 2019

SELL
$125.72 - $139.79 $75.3 Million - $83.7 Million
-599,000 Reduced 74.97%
200,000 $28 Million
Q4 2018

Feb 14, 2019

BUY
$122.84 - $147.84 $86.5 Million - $104 Million
704,000 Added 741.05%
799,000 $103 Million
Q3 2018

Nov 14, 2018

BUY
$121.58 - $142.88 $11.6 Million - $13.6 Million
95,000 New
95,000 $13.3 Million

Others Institutions Holding JNJ

About JOHNSON & JOHNSON


  • Ticker JNJ
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,614,479,872
  • Market Cap $406B
  • Description
  • Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...
More about JNJ
Track This Portfolio

Track Balyasny Asset Management LLC Portfolio

Follow Balyasny Asset Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Balyasny Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Balyasny Asset Management LLC with notifications on news.